Study of maralixibat in adults aged 16 years and older with Alagille syndrome
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Maralixibat (Primary)
- Indications Alagille syndrome
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Sep 2023 According to a Mirum Pharmaceuticals media release, data from this study will be presented at the upcoming North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) annual meeting taking place October 4-7, 2023, in San Diego, California.
- 07 Aug 2023 New trial record
- 24 Jun 2023 Results presented at the European Association for the Study of the Liver Congress 2023